ACER Insider Transactions
Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2023-03-14 | Quartel Adrian W | officer: Chief Medical Officer | 30,000 | A-Award | A | 30,000 | 1.67 | 50,100.00 |
2023-03-14 | Paul Bernard H | officer: Chief People Officer | 30,000 | A-Award | A | 30,000 | 1.67 | 50,100.00 |
2023-03-14 | PALMIN HARRY S | officer: Chief Financial Officer | 30,000 | A-Award | A | 30,000 | 1.67 | 50,100.00 |
2023-03-14 | Klopp John Michael | officer: Chief Technical Officer | 30,000 | A-Award | A | 30,000 | 1.67 | 50,100.00 |
2023-03-14 | Joseph Donald | officer: Chief Legal Officer and Secy | 30,000 | A-Award | A | 30,000 | 1.67 | 50,100.00 |
2023-03-14 | Hayden Tanya | officer: Chief Operating Officer | 30,000 | A-Award | A | 30,000 | 1.67 | 50,100.00 |
2023-03-14 | DUNN JOHN MICHAEL | director | 20,000 | A-Award | A | 20,000 | 1.67 | 33,400.00 |
2023-03-14 | GRIFFIN MICHELLE RENEE | director | 20,000 | A-Award | A | 20,000 | 1.67 | 33,400.00 |
2023-03-14 | ASELAGE STEVE | director | 20,000 | A-Award | A | 20,000 | 1.67 | 33,400.00 |
2023-03-14 | Davis Jefferson E | officer: Chief Business Officer | 30,000 | A-Award | A | 30,000 | 1.67 | 50,100.00 |
2023-03-14 | Amello Jason | director | 20,000 | A-Award | A | 20,000 | 1.67 | 33,400.00 |
2022-11-29 | ASELAGE STEVE | director | 483,741 | P-Purchase | A | 409,836 | 1.22 | 499,999.92 |
2022-11-29 | Schelling Chris | director, 10 percent owner, officer: President & CEO | 2,712,529 | P-Purchase | A | 819,672 | 1.22 | 999,999.84 |
2022-06-19 | Hayden Tanya | officer: Chief Operating Officer | 25,000 | A-Award | A | 25,000 | 1.76 | 44,000.00 |
2022-02-21 | Quartel Adrian W | officer: Chief Medical Officer | 200,000 | A-Award | A | 200,000 | 2.55 | 510,000.00 |
2022-01-14 | Paul Bernard H | officer: Chief People Officer | 25,000 | A-Award | A | 25,000 | 2.21 | 55,250.00 |
2022-01-14 | Seibt Matthew | officer: Chief Commercial Officer | 25,000 | A-Award | A | 25,000 | 2.21 | 55,250.00 |
2022-01-14 | PALMIN HARRY S | officer: Chief Opp. and Financial Offr | 25,000 | A-Award | A | 25,000 | 2.21 | 55,250.00 |
2022-01-14 | Schelling Chris | director, 10 percent owner, officer: President & CEO | 50,000 | A-Award | A | 50,000 | 2.21 | 110,500.00 |
2022-01-14 | Klopp John Michael | officer: Chief Technical Officer | 25,000 | A-Award | A | 25,000 | 2.21 | 55,250.00 |
2022-01-14 | Joseph Donald | officer: Chief Legal Officer and Secy | 25,000 | A-Award | A | 25,000 | 2.21 | 55,250.00 |
2022-01-14 | GRIFFIN MICHELLE RENEE | director | 18,500 | A-Award | A | 18,500 | 2.21 | 40,885.00 |
2022-01-14 | Davis Jefferson E | officer: Chief Business Officer | 25,000 | A-Award | A | 25,000 | 2.21 | 55,250.00 |
2022-01-14 | DUNN JOHN MICHAEL | director | 18,500 | A-Award | A | 18,500 | 2.21 | 40,885.00 |
2022-01-14 | ASELAGE STEVE | director | 18,500 | A-Award | A | 18,500 | 2.21 | 40,885.00 |
2022-01-14 | Amello Jason | director | 18,500 | A-Award | A | 18,500 | 2.21 | 40,885.00 |
2021-12-10 | ASELAGE STEVE | director | 73,905 | P-Purchase | A | 7,984 | 2.04 | 16,287.36 |
2021-12-09 | ASELAGE STEVE | director | 65,921 | P-Purchase | A | 2,016 | 2.15 | 4,334.40 |
2021-02-03 | Davis Jefferson E | officer: Chief Business Officer | 100,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
2021-01-15 | Klopp John Michael | officer: Chief Technical Officer | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2021-01-15 | Schelling Chris | director, 10 percent owner, officer: President & CEO | 40,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
2021-01-15 | Seibt Matthew | officer: Chief Commercial Officer | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2021-01-15 | Joseph Donald | officer: Chief Legal Officer and Secy | 60,000 | A-Award | A | 60,000 | 0.00 | 0.00 |
2021-01-15 | Amello Jason | director | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
2021-01-15 | PALMIN HARRY S | officer: Chief Opp. and Financial Offr | 60,000 | A-Award | A | 60,000 | 0.00 | 0.00 |
2021-01-15 | GRIFFIN MICHELLE RENEE | director | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
2021-01-15 | DUNN JOHN MICHAEL | director | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
2021-01-15 | ASELAGE STEVE | director | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
2020-07-24 | Joseph Donald | officer: Chief Legal Officer and Secy | 14,285 | P-Purchase | A | 14,285 | 3.50 | 49,997.50 |
2020-07-24 | Schelling Chris | director, 10 percent owner, officer: President & CEO | 1,892,857 | P-Purchase | A | 142,857 | 3.50 | 499,999.50 |
2020-07-24 | ASELAGE STEVE | director | 63,905 | P-Purchase | A | 45,000 | 3.50 | 157,500.00 |
2020-07-24 | DUNN JOHN MICHAEL | director | 27,380 | P-Purchase | A | 21,428 | 3.50 | 74,998.00 |
2020-03-02 | Andrews William T. | officer: Chief Medical Officer | 5,858 | F-InKind | D | 3,142 | 3.28 | 10,305.76 |
2020-01-02 | ASELAGE STEVE | director | 9,000 | A-Award | A | 9,000 | 0.00 | 0.00 |
2020-01-02 | GRIFFIN MICHELLE RENEE | director | 9,000 | A-Award | A | 9,000 | 0.00 | 0.00 |
2020-01-02 | DUNN JOHN MICHAEL | director | 9,000 | A-Award | A | 9,000 | 0.00 | 0.00 |
2020-01-02 | Amello Jason | director | 9,000 | A-Award | A | 9,000 | 0.00 | 0.00 |
2019-09-18 | Seibt Matthew | officer: Chief Commercial Officer | 50,000 | A-Award | A | 50,000 | 0.00 | 0.00 |
2019-09-18 | Klopp John Michael | officer: Chief Technical Officer | 50,000 | A-Award | A | 50,000 | 0.00 | 0.00 |
2019-09-18 | Andrews William T. | officer: Chief Medical Officer | 40,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
2019-09-18 | Joseph Donald | officer: Chief Legal Officer and Secy | 40,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
2019-09-18 | PALMIN HARRY S | officer: Chief Opp. and Financial Offr | 40,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
2019-07-03 | ASELAGE STEVE | director | 18,905 | P-Purchase | A | 5,000 | 3.72 | 18,581.00 |
2019-03-01 | Andrews William T. | officer: Chief Medical Officer | 9,000 | A-Award | A | 9,000 | 0.00 | 0.00 |
2019-02-01 | GRIFFIN MICHELLE RENEE | director | 6,000 | A-Award | A | 6,000 | 0.00 | 0.00 |
2019-02-01 | Andrews William T. | officer: Chief Medical Officer | 27,000 | A-Award | A | 27,000 | 0.00 | 0.00 |
2019-02-01 | ASELAGE STEVE | director | 6,000 | A-Award | A | 6,000 | 0.00 | 0.00 |
2019-02-01 | PALMIN HARRY S | officer: Chief Opp. and Financial Offr | 27,000 | A-Award | A | 27,000 | 0.00 | 0.00 |
2019-02-01 | DUNN JOHN MICHAEL | director | 6,000 | A-Award | A | 6,000 | 0.00 | 0.00 |
2019-02-01 | Schelling Chris | director, 10 percent owner, officer: President & CEO | 72,500 | A-Award | A | 72,500 | 0.00 | 0.00 |
2019-02-01 | Amello Jason | director | 6,000 | A-Award | A | 6,000 | 0.00 | 0.00 |
2019-02-01 | Joseph Donald | officer: Chief Legal Officer and Secy | 27,000 | A-Award | A | 27,000 | 0.00 | 0.00 |
2018-12-04 | Jutt-Eghbali Salma | officer: Chief Commercial Officer | 60,000 | A-Award | A | 60,000 | 0.00 | 0.00 |
2018-08-01 | TVM Life Science Ventures VII L.P. | director, 10 percent owner | 1,697,709 | P-Purchase | A | 275,000 | 18.00 | 4,950,000.00 |
2018-04-20 | Joseph Donald | officer: Chief Legal Officer and Secy | 60,000 | A-Award | A | 60,000 | 0.00 | 0.00 |
2017-12-14 | ASELAGE STEVE | director | 13,905 | P-Purchase | A | 2,000 | 12.00 | 24,000.00 |
2017-12-12 | TVM Life Science Ventures VI GmbH & Co KG | director, 10 percent owner | 248,756 | P-Purchase | A | 21,271 | 12.00 | 255,252.00 |
2017-12-12 | TVM Life Science Ventures VI GmbH & Co KG | director, 10 percent owner | 725,844 | P-Purchase | A | 62,062 | 12.00 | 744,744.00 |
2017-12-12 | TVM Life Science Ventures VI GmbH & Co KG | director, 10 percent owner | 1,422,709 | P-Purchase | A | 250,000 | 12.00 | 3,000,000.00 |
2017-10-04 | Amello Jason | director | 9,000 | A-Award | A | 9,000 | 15.34 | 138,060.00 |
2017-10-04 | PALMIN HARRY S | officer: Chief Opp. and Financial Offr | 67,600 | A-Award | A | 67,600 | 15.34 | 1,036,984.00 |
2017-10-04 | ASELAGE STEVE | director | 6,000 | A-Award | A | 6,000 | 15.34 | 92,040.00 |
2017-10-04 | Andrews William T. | officer: Chief Medical Officer | 100,000 | A-Award | A | 100,000 | 15.34 | 1,534,000.00 |
2017-10-04 | GRIFFIN MICHELLE RENEE | director | 9,000 | A-Award | A | 9,000 | 15.34 | 138,060.00 |
2017-10-04 | DUNN JOHN MICHAEL | director | 6,000 | A-Award | A | 6,000 | 15.34 | 92,040.00 |
2017-10-04 | Schelling Chris | director, 10 percent owner, officer: President & CEO | 46,000 | A-Award | A | 46,000 | 15.34 | 705,640.00 |
2017-09-19 | Steiner Robert D | officer: Chief Medical Officer | 40,000 | J-Other | A | 40,000 | 2.55 | 102,000.00 |
2017-09-19 | TVM Life Science Ventures VI GmbH & Co KG | director, 10 percent owner | 227,485 | J-Other | A | 227,485 | 0.00 | 0.00 |
2017-09-19 | TVM Life Science Ventures VI GmbH & Co KG | director, 10 percent owner | 663,782 | J-Other | A | 663,782 | 0.00 | 0.00 |
2017-09-19 | DUNN JOHN MICHAEL | director | 5,952 | J-Other | A | 5,952 | 0.00 | |
2017-09-19 | DUNN JOHN MICHAEL | director | 16,000 | J-Other | A | 16,000 | 2.55 | 40,800.00 |
2017-09-19 | Schelling Chris | director, officer: President and CEO | 1,750,000 | J-Other | A | 1,750,000 | 0.00 | 0.00 |
2017-09-19 | ASELAGE STEVE | director | 11,905 | J-Other | A | 11,905 | 0.00 | |
2017-09-19 | ASELAGE STEVE | director | 21,000 | J-Other | A | 21,000 | 2.55 | 53,550.00 |
2017-09-19 | TVM Life Science Ventures VI GmbH & Co KG | director, 10 percent owner | 1,172,709 | J-Other | A | 1,172,709 | 0.00 | 0.00 |
2017-09-19 | PALMIN HARRY S | officer: Chief Financial Officer | 125,000 | J-Other | A | 125,000 | 0.00 | 0.00 |
2016-11-18 | BARABE TIMOTHY C | director | 20,719 | S-Sale | D | 7,105 | 0.55 | 3,907.75 |
2016-11-18 | BARABE TIMOTHY C | director | 0 | S-Sale | D | 16,000 | 0.01 | 94.40 |
2016-11-18 | BARABE TIMOTHY C | director | 12,910 | S-Sale | D | 7,809 | 0.55 | 4,301.98 |
2016-09-30 | Richman Michael | director | 25,884 | A-Award | A | 6,455 | 0.00 | 0.00 |
2016-09-30 | Maderis Gail J | director | 25,884 | A-Award | A | 6,455 | 0.00 | 0.00 |
2016-09-30 | Seaman Scott B | director | 29,989 | A-Award | A | 6,455 | 0.00 | 0.00 |
2016-09-30 | BARABE TIMOTHY C | director | 27,824 | A-Award | A | 6,455 | 0.00 | 0.00 |
2016-06-30 | BARABE TIMOTHY C | director | 21,369 | A-Award | A | 6,455 | 0.00 | 0.00 |
2016-06-30 | Maderis Gail J | director | 19,429 | A-Award | A | 6,455 | 0.00 | 0.00 |
2016-06-30 | Seaman Scott B | director | 23,534 | A-Award | A | 6,455 | 0.00 | 0.00 |
2016-06-30 | Richman Michael | director | 19,429 | A-Award | A | 6,455 | 0.00 | 0.00 |
2016-05-16 | Maderis Gail J | director | 12,974 | A-Award | A | 6,455 | 0.00 | 0.00 |
2016-05-16 | Healey Don | officer: Chief Scientific Officer | 50,000 | A-Award | A | 50,000 | 2.13 | 106,500.00 |
2016-05-16 | Warma Neil K | director, officer: President, CEO and Acting CFO | 50,000 | A-Award | A | 50,000 | 2.13 | 106,500.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.